TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32304676

Group type: EXPERIMENTAL
Intervention: 20% sugar tax
Number of subjects: 3584

Group type: EXPERIMENTAL
Intervention: Tiered sugar tax
Number of subjects: 3584

Group type: EXPERIMENTAL
Intervention: Multiple traffic light FOP label
Number of subjects: 3584

Group type: EXPERIMENTAL
Intervention: Health star rating FOP label
Number of subjects: 3584

Group type: COMPARATOR
Intervention: No sugar tax
Number of subjects: 3584

Group type: COMPARATOR
Intervention: No FOP label
Number of subjects: 3584
Study: 32627621

Group type: EXPERIMENTAL
Intervention: Graphic card
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine prenatal counseling
Number of subjects: 150
Study: 34941608

Group type: EXPERIMENTAL
Intervention: 3-RIR (3 repetitions in reserve)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0-RIR (0 repetitions in reserve)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 3-RIR
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0-RIR
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 3-RIR and 0-RIR
Number of subjects: 14
Study: 33385308

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (AET) for 3 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Stretching and toning program (SAT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (AET)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (AET) and Stretching and toning program (SAT)
Number of subjects: 16
Study: 35172878

Group type: EXPERIMENTAL
Intervention: Treatment holiday (TH) group: belimumab 10 mg/kg IV discontinued for 24 weeks, then restarted 10 mg/kg IV every 4 weeks for 28 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment continuation (TC) group: continued on belimumab 10 mg/kg IV plus standard therapy every 4 weeks for 52 weeks
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Long-term discontinuation (LTD) group: permanently withdrawn from further belimumab treatment
Number of subjects: 41
Study: 34188449

Group type: EXPERIMENTAL
Intervention: Neratinib plus capecitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lapatinib plus capecitabine
Number of subjects: 0
Study: 32215272

Group type: EXPERIMENTAL
Intervention: Combined resistance-aerobic training for 3 sessions during eight weeks
Number of subjects: 24
Study: 34517991

Group type: EXPERIMENTAL
Intervention: Overdentures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 0
Study: 34322921

Group type: EXPERIMENTAL
Intervention: Mandala drawing sessions (2 sessions of 1-2 hours each)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 60
Study: 32622795

Group type: EXPERIMENTAL
Intervention: OHT frailty screening tool
Number of subjects: 36790
Study: 33411567

Group type: EXPERIMENTAL
Intervention: Family-based asthma self-management program (3 sessions over 2 months)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Family-based asthma self-management program
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study: 32385825

Group type: EXPERIMENTAL
Intervention: NDD donors
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: DCD donors
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Invasive procedures
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 622
Study: 35066982

Group type: EXPERIMENTAL
Intervention: EGF-containing cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33107666

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) - 10 weekly telephone sessions
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Yoga - 20 biweekly group yoga classes
Number of subjects: 500

Group type: COMPARATOR
Intervention: Preference effect (average effect for those who received their preferred intervention)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Selection effect (effect on outcomes of self‐selection to a specific intervention)
Number of subjects: 500
Study: 33184771

Group type: EXPERIMENTAL
Intervention: Environmental diffusion essential oil therapy (EOT) combined with psychotropic drug therapy (group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Psychotropic drug therapy alone (group B)
Number of subjects: 32
Study: 36308124

Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 152

Group type: COMPARATOR
Intervention: Manual Small-Incision Cataract Surgery (MSICS)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Both MSICS and Phacoemulsification
Number of subjects: 152
Study: 33075131

Group type: EXPERIMENTAL
Intervention: Occupational Adaptation (OA) training program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Skills-based (SB) training program
Number of subjects: 28
Study: 32590969

Group type: EXPERIMENTAL
Intervention: Peer-based clubs with an empowerment curriculum
Number of subjects: 33
Study: 35705204

Group type: EXPERIMENTAL
Intervention: ILF‐NF + TAU
Number of subjects: 93

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 93
Study: 35011787

Group type: EXPERIMENTAL
Intervention: Internet-delivered, self-help comprehensive behavioral intervention for tics (ICBIT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 38
Study: 33034157

Group type: EXPERIMENTAL
Intervention: Tai chi exercise intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All participants (controlling for intervention group)
Number of subjects: 100
Study: 32989492

Group type: EXPERIMENTAL
Intervention: Transoral microdebrider (TOMD)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Transnasal microdebrider (TNMD)
Number of subjects: 63
Study: 32180294

Group type: EXPERIMENTAL
Intervention: Turmeric extract, black pepper, and ginger
Number of subjects: 60

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 60
Study: 34420543

Group type: EXPERIMENTAL
Intervention: Educational intervention based on Pender's HPM (nine 4-h training sessions and consulting support via phone contact and social media group)
Number of subjects: 202
Study: 32014293

Group type: EXPERIMENTAL
Intervention: Simulated intimidation scenario
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Video of intimidation events
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (standardized lecture only)
Number of subjects: 119
Study: 35065738

Group type: EXPERIMENTAL
Intervention: Endoscopic Balloon Dilation (EBD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fully Covered Self-Expandable Metal Stents (FCSEMS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both EBD and FCSEMS
Number of subjects: 80
Study: 34688944

Group type: EXPERIMENTAL
Intervention: AZD1222 (ChAdOx1 nCoV-19) vaccine
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 33401984

Group type: EXPERIMENTAL
Intervention: SMOF Lipid 20% infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard supportive treatment
Number of subjects: 40
Study: 33755235

Group type: EXPERIMENTAL
Intervention: Once-weekly selinexor, bortezomib, and low-dose dexamethasone (XVd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard twice-weekly bortezomib and moderate-dose dexamethasone (Vd)
Number of subjects: 0
Study: 33152284

Group type: EXPERIMENTAL
Intervention: POAI (letrozole 2.5 mg per day or anastrozole 1 mg per day for 14 days)
Number of subjects: 4480

Group type: COMPARATOR
Intervention: Control (no POAI)
Number of subjects: 4480

Group type: EXPERIMENTAL
Intervention: POAI (in HER2-negative subpopulation)
Number of subjects: 4480

Group type: EXPERIMENTAL
Intervention: POAI (in HER2-positive subpopulation)
Number of subjects: 4480

Group type: EXPERIMENTAL
Intervention: POAI
Number of subjects: 4480
Study: 33215681

Group type: EXPERIMENTAL
Intervention: Male soldiers carrying loads of 15, 35, and 55 kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Female soldiers carrying loads of 15, 35, and 55 kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both male and female soldiers carrying loads of 15, 35, and 55 kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Unloaded (BM) condition for both male and female soldiers
Number of subjects: 16
Study: 33168953

Group type: EXPERIMENTAL
Intervention: Genetic predictors of educational attainment and intelligence test performance
Number of subjects: 46846
Study: 36201969

Group type: EXPERIMENTAL
Intervention: Brisk-walking/jogging for 30 min, 2 sessions separated by 24 hours
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sedentary activities for 30 min
Number of subjects: 12
Study: 33080002

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 3924

Group type: COMPARATOR
Intervention: Control (non-tocilizumab treatment)
Number of subjects: 3924
Study: 32332209

Group type: EXPERIMENTAL
Intervention: nabiximols
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cannabis
Number of subjects: 0
Study: 36173670

Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet
Number of subjects: 62

Group type: COMPARATOR
Intervention: Foot reflexology
Number of subjects: 62
Study: 32631801

Group type: EXPERIMENTAL
Intervention: Active learning education (n = 36)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Health education class (didactic) (n = 59)
Number of subjects: 95
Study: 32718158

Group type: EXPERIMENTAL
Intervention: Online imaginal and psychoeducational interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imaginal contact with a person of color
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Learning and reflecting about racism and its impact on people of color
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing awareness of White privilege and positionality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined intervention components
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control components
Number of subjects: 0
Study: 35678062

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) plus Exercise Therapy (ET)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-Intensity Pulsed Ultrasound (LIPUS) plus Exercise Therapy (ET)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Exercise Therapy (ET)
Number of subjects: 60
Study: 32113972

Group type: EXPERIMENTAL
Intervention: Bilateral plantar fascia manual pressure and traction technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tactile stimulation
Number of subjects: 40
Study: 34622567

Group type: EXPERIMENTAL
Intervention: liraglutide (≤1.8 mg/d)
Number of subjects: 1991

Group type: COMPARATOR
Intervention: oral antidiabetic drug (OAD)
Number of subjects: 1991

Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 1991

Group type: COMPARATOR
Intervention: OAD
Number of subjects: 1991
Study: 33726724

Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicine (CAM) use
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Natural remedies
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Self-help practices
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Therapies from CAM providers
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: CAM therapies from physicians
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Mean number of visits to herbalists
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Mean number of visits to healers
Number of subjects: 2001

Group type: EXPERIMENTAL
Intervention: Perceived helpfulness of CAM
Number of subjects: 2001
Study: 33412932

Group type: EXPERIMENTAL
Intervention: recall + Tetris
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: recall + eye movements (EMs)
Number of subjects: 45

Group type: COMPARATOR
Intervention: recall‐only
Number of subjects: 45
Study: 32658817

Group type: EXPERIMENTAL
Intervention: Family-focused therapy (FFT)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Enhanced care (EC)
Number of subjects: 127
Study: 33100131

Group type: EXPERIMENTAL
Intervention: DNA methylation at CpG sites (cg04816311, cg10254690, cg07660512)
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Seven identified CpGs associated with at least one trait (cg21134922, cg04816311, cg09155024, cg10254690, cg07660512, cg12661888, cg02264946)
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: Three CpGs (cg04816311, cg10254690, cg07660512)
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: DNA methylation
Number of subjects: 961
Study: 32991534

Group type: EXPERIMENTAL
Intervention: CG-CAHPS survey
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-CAHPS surveys
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: CAHPS measures
Number of subjects: 105
Study: 34853187

Group type: EXPERIMENTAL
Intervention: Downhill running (DR: ‐15% slope)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Level running (0%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Uphill running (UR: 15%)
Number of subjects: 8
Study: 33434227

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Focused attention (FA)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Open monitoring (OM)
Number of subjects: 104
Study: 35999431

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 255
Study: 32790073

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone
Number of subjects: 238

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 238
Study: 35778465

Group type: EXPERIMENTAL
Intervention: High-definition tDCS (HD-tDCS) at 1 mA to S1
Number of subjects: 45
Study: 32873669

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 supplementation
Number of subjects: 0
Study: 35260459

Group type: EXPERIMENTAL
Intervention: Cervical mobilisations targeting the painful and/or restricted cervical segments and a distraction manipulation of the cervicothoracic junction (N=75)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo mobilisation and placebo manipulation (N=25)
Number of subjects: 100
Study: 33860313

Group type: EXPERIMENTAL
Intervention: Follitropin alfa (GONAL-f; Merck KGaA)
Number of subjects: 8085
Study: 34001059

Group type: EXPERIMENTAL
Intervention: FOLFIRINOX plus regorafenib
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: FOLFIRINOX (oxaliplatin 85 mg/m2, folinic acid 400 mg/m2, irinotecan 150–180 mg/m2, 5‐fluorouracil: 400 mg/m2 then 2400 mg/m2 over 46 h) every 14 days with regorafenib (80 to 160 mg, orally, once daily on days 4 to 10 of each cycle)
Number of subjects: 69
Study: 33498539

Group type: EXPERIMENTAL
Intervention: Mind Maps
Number of subjects: 45
Study: 35104832

Group type: EXPERIMENTAL
Intervention: High-Fidelity Patient Simulation (HFPS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Flipped Classroom (FC)
Number of subjects: 82
Study: 32746455

Group type: EXPERIMENTAL
Intervention: COVID-19 hospitalization
Number of subjects: 1877

Group type: COMPARATOR
Intervention: Medical admission (2019)
Number of subjects: 1877

Group type: COMPARATOR
Intervention: COVID-19 hospitalization vs. Medical admission (2019)
Number of subjects: 1877
Study: 35714891

Group type: EXPERIMENTAL
Intervention: VascQOL
Number of subjects: 1830

Group type: EXPERIMENTAL
Intervention: EQ5D
Number of subjects: 1830

Group type: EXPERIMENTAL
Intervention: SF-12
Number of subjects: 1830
Study: 32927858

Group type: EXPERIMENTAL
Intervention: Manual therapy + Exercise
Number of subjects: 58

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 58
Study: 35129113

Group type: EXPERIMENTAL
Intervention: Endometrial scratch
Number of subjects: 1048

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1048
Study: 35339280

Group type: EXPERIMENTAL
Intervention: Tranilast (300 mg daily) for 7 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (antiviral therapy only)
Number of subjects: 72
Study: 33755924

Group type: EXPERIMENTAL
Intervention: Vafidemstat
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 32644875

Group type: EXPERIMENTAL
Intervention: Estradiol (E2) dose
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: Higher serum E2 levels
Number of subjects: 1513
Study: 34882632

Group type: EXPERIMENTAL
Intervention: Changing surgical instruments before wound closure (Group A)
Number of subjects: 453

Group type: COMPARATOR
Intervention: Conventional closure (Group B)
Number of subjects: 453
Study: 32988567

Group type: EXPERIMENTAL
Intervention: Twin-block (TB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mono-block (MB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Herbst (H)
Number of subjects: 60
Study: 35107058

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance moderate intensity continuous training (C-MICT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Combined aerobic and resistance high-intensity interval training (C-HIIT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study: 34161565

Group type: EXPERIMENTAL
Intervention: Let's Talk About Pain training
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 158
Study: 34269885

Group type: EXPERIMENTAL
Intervention: LED
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CP
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: LED/CP
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: HP
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: LED/HP
Number of subjects: 90
Study: 34778144

Group type: EXPERIMENTAL
Intervention: Promelaxin microenemas
Number of subjects: 153

Group type: COMPARATOR
Intervention: PEG 4000
Number of subjects: 153
Study: 34087115

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 931

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 931
Study: 34468414

Group type: EXPERIMENTAL
Intervention: High-intensity isometric exercise
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-intensity isometric exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 48
Study: 32553417

Group type: EXPERIMENTAL
Intervention: GentleWave System (GWS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment with conventional side-vented needle irrigation and ultrasonic activation (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (GWS and Control)
Number of subjects: 0
Study: 34872102

Group type: EXPERIMENTAL
Intervention: Peripheral low‐concentration (10 µg/mL) norepinephrine infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%) infusion
Number of subjects: 60
Study: 36037679

Group type: EXPERIMENTAL
Intervention: Milvexian (oral small-molecule inhibitor of FXIa)
Number of subjects: 2366

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2366
Study: 33607802

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Torasemide
Number of subjects: 100
Study: 32749411

Group type: EXPERIMENTAL
Intervention: i-C3H7O radicals dissociated at 248 nm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: i-C3H7O undergoing three-body fragmentation
Number of subjects: 0
Study: 36067616

Group type: EXPERIMENTAL
Intervention: R + L (ribociclib plus letrozole)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 106
Study: 34671228

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 100
Study: 36707979

Group type: EXPERIMENTAL
Intervention: CBT + ABM
Number of subjects: 23

Group type: COMPARATOR
Intervention: CBT + PBO
Number of subjects: 23
Study: 33512079

Group type: EXPERIMENTAL
Intervention: High CRP levels
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Low CRP levels
Number of subjects: 337

Group type: COMPARATOR
Intervention: Control group (no lab tests provided)
Number of subjects: 337
Study: 32521891

Group type: EXPERIMENTAL
Intervention: TACE + 125I + 3DCRT
Number of subjects: 110

Group type: COMPARATOR
Intervention: TACE + 3DCRT
Number of subjects: 110
Study: 33358206

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham laser treatment
Number of subjects: 18
Study: 32447436

Group type: EXPERIMENTAL
Intervention: Information from articles
Number of subjects: 13

Group type: COMPARATOR
Intervention: Additional sources of information
Number of subjects: 13
Study: 35692220

Group type: EXPERIMENTAL
Intervention: Favipiravir + camostat + ciclesonide combination therapy
Number of subjects: 121

Group type: COMPARATOR
Intervention: Favipiravir monotherapy
Number of subjects: 121
Study: 36068002

Group type: EXPERIMENTAL
Intervention: Intralesional collagenase Clostridium histolyticum (CCH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intralesional verapamil (ILV)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall patient satisfaction
Number of subjects: 50
Study: 33762129

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 60

Group type: COMPARATOR
Intervention: tACS
Number of subjects: 60
Study: 34321055

Group type: EXPERIMENTAL
Intervention: Personalised text message (including recipient's name)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Standard text message
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Personalised text message
Number of subjects: 618
Study: 616354713

Group type: EXPERIMENTAL
Intervention: Helmet therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Postural correction training
Number of subjects: 31
Study: 35652769

Group type: EXPERIMENTAL
Intervention: 20 mL 70% alcohol (CPN20 group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 40 mL 70% alcohol (CPN40 group)
Number of subjects: 32
Study: 34070257

Group type: EXPERIMENTAL
Intervention: Intervention 1 (IG-1, n = 26) - received resistance and balance training three days a week in addition to usual inpatient CR program
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Intervention 2 (IG-2, n = 18) - received different resistance and balance training three days a week in addition to usual inpatient CR program
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (CG, n = 19) - attended usual inpatient CR program
Number of subjects: 63